mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.1 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.1 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.081 |
0.1 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.1 |